Getting an IV line started can be a stressful experience for patients. It often involves multiple needle sticks and discomfort. New data from a review of clinical trials suggests that mini midlines (MMCs) might offer a better experience than standard peripheral catheters (PIVCs) for those needing intravenous therapy.
Researchers looked at data from 1,175 patients to compare these two methods. They found that mini midlines had a significantly higher success rate for the first needle poke. They also required fewer attempts to get the line started and stayed in place better than standard catheters.
In addition to better performance, the study found that mini midlines were safer than standard options. While the data shows these improvements in success and safety, the specific numbers for each outcome were not provided in this summary. Talk to your healthcare team to see if this option is right for your specific needs.
What this means for you:
Mini midlines are more successful, last longer, and are safer than standard peripheral catheters for IV therapy.
Common questions
How do mini midlines compare to standard IV catheters?
Mini midlines are superior to standard peripheral catheters in several ways. They have a higher success rate for the first needle poke, require fewer attempts to start, and stay in place better. The study also found that mini midlines are safer for patients who need intravenous therapy.
Are mini midlines safer for patients?
Yes, the study found that mini midlines are superior to standard peripheral catheters in terms of safety. While the data confirms they are safer, you should always speak with your doctor to discuss the best and safest options for your specific medical situation.
Do mini midlines stay in place longer?
Yes, the research indicates that mini midlines have superior retention characteristics compared to standard peripheral catheters. This means they are more likely to stay in place during treatment, which can lead to a better experience for the patient.
